Browse By Cell Line Result Page of OvirusTdb

The total number of records retrieved from this search are 28. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_943Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSKNBE4.0E+3 cells per wellNANA10 virus particle/cell80% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_944Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSKNBE4.0E+3 cells per wellNANA100 virus particle/ cell70% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_945Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSKNBE4.0E+3 cells per wellNANA1000 virus particle/ cell70% cancer cell survival after 6 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_946Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSKNBE4.0E+3 cells per wellNANA10000 virus particle/ cell80% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_975Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSKNBE4.0E+3 cells per wellNANA10 virus particle/cell80% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_976Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSKNBE4.0E+3 cells per wellNANA100 virus particle/ cell80% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_977Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSKNBE4.0E+3 cells per wellNANA1000 virus particle/ cell50% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_978Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSKNBE4.0E+3 cells per wellNANA10000 virus particle/ cell20% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1055Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSKNBE4.0E+3 cells per wellNANA10 pfu/cell100% cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1056Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSKNBE4.0E+3 cells per wellNANA100 pfu/cell80% cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1057Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSKNBE4.0E+3 cells per wellNANA1000 pfu/cell75% cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1058Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSKNBE4.0E+3 cells per wellNANA10000 pfu/cell30% cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1059Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSKNBE4.0E+3 cells per wellNANA10 pfu/cell100% cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1060Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSKNBE4.0E+3 cells per wellNANA100 pfu/cell20% cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1061Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSKNBE4.0E+3 cells per wellNANA1000 pfu/cell20% cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1062Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSKNBE4.0E+3 cells per wellNANA10000 pfu/cell100% cell killing after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1063Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSKNBE4.0E+3 cells per wellNANA10 pfu/cell100% cell survival after 6 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1064Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSKNBE4.0E+3 cells per wellNANA100 pfu/cell100% cell killing after 6 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1065Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSKNBE4.0E+3 cells per wellNANA1000 pfu/cell100% cell killing after 6 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1066Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSKNBE4.0E+3 cells per wellNANA10000 pfu/cell100% cell killing after 6 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1067Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSKNBE4.0E+3 cells per wellNANA10 pfu/cell100% cell survival after 8 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1068Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSKNBE4.0E+3 cells per wellNANA100 pfu/cell100% cell killing after 8 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1069Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSKNBE4.0E+3 cells per wellNANA1000 pfu/cell100% cell killing after 8 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1070Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSKNBE4.0E+3 cells per wellNANA10000 pfu/cell100% cell killing after 8 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_2891Vaccinia virusvvDDDNAPoxviridaeDeletion of TK gene and vaccinia growth factorYesNoNoLaboratory grown own cultureNeuroblastoma cell lineSKNBE25.0E+3 cells per wellNAMTT assay0.01 MOI50% cell survivalNoNoNA No responseNANANANA23816608
OV_2892Vaccinia virusvvDDDNAPoxviridaeDeletion of TK gene and vaccinia growth factorYesNoNoLaboratory grown own cultureNeuroblastoma cell lineSKNBE25.0E+3 cells per wellNAMTT assay0.1 MOI40% cell survivalNoNoNA No responseNANANANA23816608
OV_2893Vaccinia virusvvDDDNAPoxviridaeDeletion of TK gene and vaccinia growth factorYesNoNoLaboratory grown own cultureNeuroblastoma cell lineSKNBE25.0E+3 cells per wellNAMTT assay1 MOI38% cell survivalNoNoNA No responseNANANANA23816608
OV_2894Vaccinia virusvvDDDNAPoxviridaeDeletion of TK gene and vaccinia growth factorYesNoNoLaboratory grown own cultureNeuroblastoma cell lineSKNBE25.0E+3 cells per wellNAMTT assay10 MOI20% cell survivalNoNoNA No responseNANANANA23816608